Greece vs Switzerland: Adults (ages 15+) and children (0-14 years) living with HIV
Greece
17,000
in 2024
Switzerland
18,000
in 2024
Greece rank
86th
Switzerland rank
84th
Adults (ages 15+) and children (0-14 years) living with HIV over time
- Greece
- Switzerland
How they compare
Switzerland currently reports 18,000 against 17,000 in Greece, a difference of 1,000.
That makes Switzerland's figure about 1.1 times Greece's.
Across all 35 years both countries report, Switzerland has been ahead every year.
Greece ranks 86th and Switzerland ranks 84th of 152 countries.
Switzerland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Greece | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2,470 | 7,680 | 5,210 | Switzerland |
| 2000s | 6,370 | 11,500 | 5,130 | Switzerland |
| 2010s | 12,260 | 15,400 | 3,140 | Switzerland |
| 2020s | 16,200 | 17,600 | 1,400 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (0-14 years) living with hiv, Greece or Switzerland?
- Switzerland, at 18,000 against 17,000 in Greece as of 2024.
- What is the difference in adults (ages 15+) and children (0-14 years) living with hiv between Greece and Switzerland?
- 1,000, with Switzerland ahead.
- How many years of comparable data are there for Greece and Switzerland?
- 35 years are reported by both, from 1990 to 2024.
- How do Greece and Switzerland rank globally for adults (ages 15+) and children (0-14 years) living with hiv?
- Greece ranks 86th and Switzerland ranks 84th of 152 countries.
- Where does this data come from?
- UNAIDS estimates, published as Adults (ages 15+) and children (0-14 years) living with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Adults and children living with HIV refers to the number of people ages 0-49 (adult ages 15-49 and children ages 0-14) who are infected with HIV.